ARS Pharmaceuticals, Inc (SPRY) — Free Cash Flow Generation Index
ARS Pharmaceuticals, Inc (SPRY) has a Free Cash Flow Generation Index of 0.99x as of December 2024. Free cash flow of $41.70 Million represents 1% of operating cash flow ($42.00 Million). Explore ARS Pharmaceuticals, Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ARS Pharmaceuticals, Inc Free Cash Flow Generation Index (2020–2024)
Historical FCF Generation Index trend for ARS Pharmaceuticals, Inc across 2 annual periods. For the full cash flow conversion analysis, see ARS Pharmaceuticals, Inc (SPRY) cash flow conversion.
Annual Free Cash Flow Generation for ARS Pharmaceuticals, Inc (2020–2024)
Year-by-year Free Cash Flow Generation Index for ARS Pharmaceuticals, Inc. Check how aggressively does ARS Pharmaceuticals, Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.96x | $12.98 Million | $13.55 Million | $563.00K | ▲ +6.6% |
| 2020 | 0.90x | $8.15 Million | $9.07 Million | $917.00K | — |